Covadonga Pañeda
Director de Operaciones en ALTAMIRA THERAPEUTICS LTD. .
Cargos activos de Covadonga Pañeda
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Director de Operaciones | 01/01/2023 | - |
| Corporate Officer/Principal | - | 01/01/2023 |
Historial de carrera de Covadonga Pañeda
Antiguos cargos conocidos de Covadonga Pañeda.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Corporate Officer/Principal | 01/10/2020 | 01/04/2022 |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Director Técnico/Científico/I+D | 01/03/2011 | 01/06/2018 |
Formación de Covadonga Pañeda.
| Universidad Autónoma de Madrid | Doctorate Degree |
Estadísticas
Internacional
| España | 3 |
| Bermudas | 2 |
| Francia | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
- Bolsa de valores
- Insiders
- Covadonga Pañeda
- Experiencia